Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma

Zhong Zheng(Chinese University of Hong Kong), Xiangshan Fan(Anhui Medical University), Yao Fu(Illumina (United States)), Hongyan Wu(Hong Kong Baptist University), Ting Wang(Nanjing Drum Tower Hospital), Jiong Shi(Nanjing Drum Tower Hospital), Huiping Yu(Nanjing Drum Tower Hospital), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region)
Oncotarget
December 12, 2017
10.18632/oncotarget.23144
Cited by 20

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
|PubMed|1994|485
Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva
|Gynecologic Oncology|1990|430
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396